The Indian drugmaker expects regulatory approval for its vaccine against Covid-19 by June. Efficacy readings from its last stage of clinical trials are expected in May.
Cadila is looking to hire contract manufacturers for additional 50-70 million doses of its vaccine, on top of 100 million that will come from its own capacity.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS